Loading...
XHKG0455
Market cap44mUSD
Dec 27, Last price  
0.16HKD
Name

Tianda Pharmaceuticals Ltd

Chart & Performance

D1W1MN
XHKG:0455 chart
P/E
—
P/S
0.65
EPS
—
Div Yield, %
1.62%
Shrs. gr., 5y
—
Rev. gr., 5y
0.19%
Revenues
532m
-2.67%
10,112,80515,207,86519,970,01436,303,71056,936,40682,951,039206,346,20197,276,705180,213,975247,173,069139,366,849192,784,764195,538,964361,554,649527,002,819491,475,099474,332,111509,955,045546,693,299532,089,000
Net income
-24m
L-55.79%
-654,2776,483,346-37,067,156-112,916,9372,751,75721,287,09267,426,46543,095,59537,740,06222,049,566-17,941,9696,568,59112,442,26510,007,7562,657,1738,800,206-25,917,806-21,674,768-54,635,863-24,155,000
CFO
-50m
L
-1,335,580-812,0802,564,11916,117,33712,634,21338,744,38451,037,08966,281,588127,901,88057,695,269-16,256,95713,443,86737,179,69058,737,82919,169,440-19,902,305-37,634,821-8,225,59079,114,000-49,757,000
Dividend
Jun 13, 20240.0026 HKD/sh
Earnings
Jun 06, 2025

Profile

Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
URL
https://www.tiandapharma.com/
IPO date
Mar 30, 1992
Employees
820
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
532,089
4.34%
546,693
15.26%
509,955
7.51%
Cost of revenue
561,112
616,838
554,052
Unusual Expense (Income)
NOPBT
(29,023)
(70,144)
(44,097)
NOPBT Margin
Operating Taxes
(689)
(4,863)
(6,343)
Tax Rate
NOPAT
(28,334)
(65,282)
(37,755)
Net income
(24,155)
11.44%
(54,636)
110.80%
(21,675)
-16.37%
Dividends
(5,588)
(17,625)
(8,557)
Dividend yield
1.19%
2.02%
1.71%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
102,170
70,304
61,862
Long-term debt
20,174
85,150
111,111
Deferred revenue
93
194
Other long-term liabilities
Net debt
(49,314)
(185,564)
(148,213)
Cash flow
Cash from operating activities
(49,757)
79,114
(8,226)
CAPEX
(49,278)
(24,386)
(53,758)
Cash from investing activities
(69,101)
(12,204)
86,350
Cash from financing activities
(57,394)
(28,980)
(1,295)
FCF
49,363
103,598
41,198
Balance
Cash
162,442
343,444
334,001
Long term investments
9,216
(2,426)
(12,816)
Excess cash
145,054
313,683
295,687
Stockholders' equity
227,279
289,580
247,325
Invested Capital
560,484
502,088
698,134
ROIC
ROCE
EV
Common stock shares outstanding
2,150,042
2,150,042
2,150,042
Price
0.22
-6.44%
0.41
100.50%
0.23
15.35%
Market cap
468,709
-6.44%
870,767
100.50%
500,960
15.35%
EV
419,265
711,614
385,068
EBITDA
7,384
(19,895)
(21,948)
EV/EBITDA
56.78
Interest
4,946
7,487
725
Interest/NOPBT